FDAFDA · Food and drugs·Recall number D-1566-2020
Cephalexin for Oral Suspension, USP 250 mg per 5 mL, For Reconstitution, For Oral Use Only, Rx Only, 100 mL bottle when mixed, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0093-4177-73.
Published September 16, 2020 · Recall initiated: August 24, 2020
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Sub-Potent Drug: Out of specification test results for potency (below specification).
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- CEPHALEXIN
- Manufacturer
- Teva Pharmaceuticals USA
- Distributor
- Nationwide in the U.S. and Puerto Rico.
- UPC
- 0300934175738
- Lot
- Lot #: 30310638A, Exp. 02/2022
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.